Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy

Abstract excerpt

The search for innovative anti-cancer drugs remains a challenge. Over the past three decades, antibodies have emerged as an essential asset in successful cancer therapy. The major obstacle in developing anti-cancer antibodies is the need for non-immunogenic antibodies against human antigens. This unique requirement highlights a disadvantage to using traditional hybridoma technology and thus demands alternative...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced Biosensing Techniques and Applications
• Share to CAR-T cell therapy research
• Share to Monoclonal and Polyclonal Antibodies Research